US earnings season, Sygnia’s new product and how Omnia managed to turn the ship around
Mia Kruger of Kruger International on the start of US earnings season, medical stocks and Sun International selling assets. Magda Wierzycka CEO Sygnia on the Sygnia Oxford Sciences Innovation Fund offering VC-type investing in an endowment structure. Omnia CEO Seelan Gobalsamy on managing a turn around.
Simon Brown
15 Jul 2020 07:09
Get full access to 
's financial insights and support quality journalism.
Only R63 per month or R630 per year. You can cancel at any time.
COMMENTS 0
You must be signed in to comment.
SIGN IN SIGN UP